Fox Run Management’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $2.12M | Buy |
+8,293
| New | +$2.04M | 0.25% | 64 |
|
|
2025
Q4 | – | Sell |
-8,634
| Closed | -$1.75M | – | 1255 |
|
|
2025
Q3 | $1.75M | Buy |
8,634
+7,282
| +539% | +$1.29M | 0.27% | 50 |
|
|
2025
Q2 | $238K | Sell |
1,352
-1,166
| -46% | -$176K | 0.04% | 707 |
|
|
2025
Q1 | $339K | Sell |
2,518
-2,801
| -53% | -$369K | 0.05% | 633 |
|
|
2024
Q4 | $671K | Buy |
5,319
+2,838
| +114% | +$422K | 0.12% | 329 |
|
|
2024
Q3 | $412K | Sell |
2,481
-4,148
| -63% | -$627K | 0.09% | 430 |
|
|
2024
Q2 | $882K | Buy |
+6,629
| New | +$798K | 0.17% | 218 |
|
|
2024
Q1 | – | Sell |
-9,270
| Closed | -$701K | – | 1055 |
|
|
2023
Q4 | $701K | Buy |
9,270
+4,405
| +91% | +$279K | 0.18% | 184 |
|
|
2023
Q3 | $321K | Sell |
4,865
-10,471
| -68% | -$783K | 0.09% | 417 |
|
|
2023
Q2 | $1.25M | Buy |
+15,336
| New | +$1.09M | 0.35% | 33 |
|
|
2022
Q3 | – | Sell |
-3,873
| Closed | -$204K | – | 824 |
|
|
2022
Q2 | $204K | Buy |
+3,873
| New | +$270K | 0.1% | 412 |
|
|
2021
Q2 | – | Sell |
-6,729
| Closed | -$350K | – | 443 |
|
|
2021
Q1 | $350K | Sell |
6,729
-210
| -3% | -$10.6K | 0.63% | 44 |
|
|
2020
Q4 | $277K | Sell |
6,939
-8,366
| -55% | -$270K | 0.56% | 67 |
|
|
2020
Q3 | $375K | Buy |
+15,305
| New | +$391K | 0.94% | 15 |
|
|
2020
Q1 | – | Sell |
-8,468
| Closed | -$322K | – | 354 |
|
|
2019
Q4 | $322K | Buy |
+8,468
| New | +$254K | 0.26% | 163 |
|
|
2019
Q3 | – | Sell |
-14,657
| Closed | -$303K | – | 559 |
|
|
2019
Q2 | $303K | Buy |
+14,657
| New | +$338K | 0.2% | 225 |
|
|
2018
Q4 | – | Sell |
-16,958
| Closed | -$483K | – | 720 |
|
|
2018
Q3 | $483K | Buy |
+16,958
| New | +$560K | 0.21% | 183 |
|
|
2018
Q1 | – | Sell |
-11,675
| Closed | -$177K | – | 914 |
|
|
2017
Q4 | $177K | Sell |
11,675
-39,025
| -77% | -$549K | 0.05% | 591 |
|
|
2017
Q3 | $833K | Buy |
50,700
+3,100
| +7% | +$52.6K | 0.24% | 112 |
|
|
2017
Q2 | $921K | Buy |
+47,600
| New | +$830K | 0.32% | 52 |
|
|
2016
Q4 | – | Sell |
-16,500
| Closed | -$374K | – | 666 |
|
|
2016
Q3 | $374K | Buy |
+16,500
| New | +$429K | 0.22% | 185 |
|
|
2016
Q2 | – | Sell |
-13,800
| Closed | -$399K | – | 666 |
|
|
2016
Q1 | $399K | Buy |
+13,800
| New | +$359K | 0.27% | 141 |
|
Other funds holding THC
Fox Run Management's THC Position: Q3 2026 in Review
Fox Run Management opened a new position in Tenet Healthcare (THC) in Q3 2026: 8,293 shares worth $2.12M. The stake represents 0.25% of the portfolio and ranks #64 among its holdings. This is a return to the name: Fox Run Management previously reported a position in THC as recently as Q3 2025.
Fox Run Management first reported a position in THC in Q1 2016 and has held it in 22 quarters since. 782 funds tracked by Wall St. Rank hold THC as of Q3 2026.
- Fox Run Management held 8,293 shares of Tenet Healthcare worth $2.12M as of Q3 2026.
- Tenet Healthcare was a new Fox Run Management position in Q3 2026.
- Tenet Healthcare made up 0.25% of Fox Run Management's portfolio in Q3 2026, its #64 holding.
- Fox Run Management first reported a position in Tenet Healthcare in Q1 2016 and has held it in 22 quarters since.
- 782 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.
Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.